European Market Report for Insulin Pens 2016 - MedCore
|発行||iData Research Inc.||商品コード||370969|
|出版日||ページ情報||英文 96 Pages
|欧州のインスリンペン市場 European Market Report for Insulin Pens 2016 - MedCore|
|出版日: 2016年09月01日||ページ情報: 英文 96 Pages||
The total European market for insulin pens comprises the prefilled pen segment, the pen cartridge segment, the pen needle segment and the safety pen needle segment. In 2015, the largest segment in the total insulin pen market was the prefilled pen segment, which represented over 80% of the total market value. Prefilled pens account for such a large portion of the market because they are highly preferred to reusable pens by diabetic patients. It is expected that this trend will continue over the forecast period, as reusable pens do not offer a financial incentive and essentially perform the same function as prefilled pens. Growth of the segment will be driven by unit sales growth and modest ASP appreciation of the overall insulin market.
Insulin pens are shaped like a writing pen, but have a reservoir for insulin and are used as a delivery method for insulin. To administer insulin, patients must remove the pen cap, clean the injection site with an alcohol swab, attach a pen needle, prime the pen, dial the appropriate dosage amount and finally inject the insulin. There is a dose dial on the side of the pen so the patient can choose the required dose.
Insulin pens are either prefilled or reusable with a disposable cartridge component, and generally carry 300 units of insulin. Most brands of insulin are available in pen format. This delivery method offers several advantages over the traditional vial and syringe delivery method. Pens offer ease-of-handling, improved accuracy, more discreet use and less injection pain.